Nom du produit:1-Methyl-7-(trifluoromethyl)-1H-indazole-3-carboxamide

IUPAC Name:1-methyl-7-(trifluoromethyl)-1H-indazole-3-carboxamide

CAS:1638591-49-7
Formule moléculaire:C10H8F3N3O
Pureté:97%
Numéro de catalogue:CM256951
Poids moléculaire:243.19

Unité d'emballage Stock disponible Prix($) Quantité
CM256951-100mg in stock NJȎǵ
CM256951-250mg 1-2 Weeks ưĽů
CM256951-500mg 1-2 Weeks ƓƓʼnȎ
CM256951-1g 1-2 Weeks Ɠʼnǵǵ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1638591-49-7
Formule moléculaire:C10H8F3N3O
Point de fusion:-
Code SMILES:O=C(C1=NN(C)C2=C1C=CC=C2C(F)(F)F)N
Densité:
Numéro de catalogue:CM256951
Poids moléculaire:243.19
Point d'ébullition:
N° Mdl:MFCD28502803
Stockage:

Category Infos

Indazoles
Indazoles are a class of organic heterocyclic compounds, also known as 1,2-diazaindene and benzopyrazole. Indazole is a good bioisomer of phenol, which is more lipophilic than phenol and less prone to phase I and II metabolism. Indazole derivatives have a wide range of biological activities, and it has been confirmed that indazole compounds have anti-tumor, analgesic, anti-inflammatory and other drug activities. Anticancer is the most important application field of indazole drugs. Renal cell carcinoma, solid tumor, nausea and vomiting caused by chemotherapy and leukemia are the main indications of this structural backbone drug.

Related Products